{"id":37225,"date":"2021-11-25T10:37:00","date_gmt":"2021-11-25T10:37:00","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=37225"},"modified":"2021-11-25T10:45:50","modified_gmt":"2021-11-25T10:45:50","slug":"holger-krenz","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/holger-krenz\/","title":{"rendered":"Holger Krenz"},"content":{"rendered":"<div class=\"vgblk-rw-wrapper limit-wrapper\">\n\n\t<h2>Holger Krenz<\/h2>\n<h4>Vice President Applications Development Europe at SiO2 Material Science<\/h4>\n\t<p>Holger Krenz, Vice President Applications Development Europe, at SiO2 Material Science, is together with his team responsible for the European customer activities to support the commercialization of SiO2\u00b4s product portfolio. He is a biologist with a focus on Neurophysiology working for the last 20 years in the medical device and pharmaceutical packaging industry. Holger worked in various positions including R&amp;D project management as well as sales and business development at different companies e.g. Boehringer Ingelheim and WestRock \/ Silgan Dispensing. In 2014 he joined SiO2 Material Science.<\/p>\n\t\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Holger-Krenz_BioTech_Pharma_Summit_2021_gallery.jpg\" alt=\"Holger Krenz_BioTech_Pharma_Summit_2021_gallery\" itemprop=\"image\" height=\"1224\" width=\"820\" title=\"Holger Krenz_BioTech_Pharma_Summit_2021_gallery\" onerror=\"this.style.display='none'\"  sizes=\"auto, (max-width: 768px) 100vw, 100vw\" srcset=\"data:image\/svg+xml;utf8,&lt;svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/&gt;\" data-srcset=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Holger-Krenz_BioTech_Pharma_Summit_2021_gallery.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Holger-Krenz_BioTech_Pharma_Summit_2021_gallery-201x300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Holger-Krenz_BioTech_Pharma_Summit_2021_gallery-686x1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Holger-Krenz_BioTech_Pharma_Summit_2021_gallery-768x1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Holger-Krenz_BioTech_Pharma_Summit_2021_gallery-630x940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Holger-Krenz_BioTech_Pharma_Summit_2021_gallery-420x627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Holger-Krenz_BioTech_Pharma_Summit_2021_gallery-315x470.jpg 315w\" \/>\t\t\t\t\t\t\t\n<h3>\n\tTitle: Beyond glass &#8211; benefits for biological drugs of a new hybrid material for primary packaging container\n\t<\/h3>\n<h4>\n\t\t\t<a href=\"#\" title=\"On the Web\" target=\"_self\" rel=\"noopener\">\n\tOn the Web\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/www.sio2ms.com\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.sio2ms.com\/<\/a><\/p>\n<h4>\n\t\t\t<a href=\"#\" title=\"On LinkedIn\" target=\"_self\" rel=\"noopener\">\n\tOn LinkedIn\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/www.linkedin.com\/in\/holger-krenz-6525b690\/\" target=\"_blank\" rel=\"noopener\">Visit Profile<\/a><\/p>\n\n<\/div><!-- .vgblk-rw-wrapper -->","protected":false},"excerpt":{"rendered":"<p>Holger Krenz Vice President Applications Development Europe at SiO2 Material Science Holger Krenz, Vice President Applications Development Europe, at SiO2 Material Science, is together with his team responsible for the European customer activities to support the commercialization of SiO2\u00b4s product portfolio. He is a biologist with a focus on Neurophysiology working for the last 20&#8230;<\/p>\n","protected":false},"author":1,"featured_media":37226,"parent":35042,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-37225","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Holger Krenz &#8226; BioTech Pharma Summit<\/title>\n<meta name=\"description\" content=\"Holger Krenz, Vice President Applications Development Europe, at SiO2 Material Science, is together with his team responsible for the European customer activities to support the commercialization of SiO2\u00b4s product portfolio.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/holger-krenz\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Holger Krenz &#8226; BioTech Pharma Summit\" \/>\n<meta property=\"og:description\" content=\"Holger Krenz, Vice President Applications Development Europe, at SiO2 Material Science, is together with his team responsible for the European customer activities to support the commercialization of SiO2\u00b4s product portfolio.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/holger-krenz\/\" \/>\n<meta property=\"og:site_name\" content=\"BioTech Pharma Summit\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/biotechpharmasummit\/\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-25T10:45:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Holger-Krenz_BioTech_Pharma_Summit_2021_Profile.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@biotechsummit\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/holger-krenz\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/holger-krenz\/\",\"name\":\"Holger Krenz &#8226; BioTech Pharma Summit\",\"isPartOf\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/holger-krenz\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/holger-krenz\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Holger-Krenz_BioTech_Pharma_Summit_2021_Profile.jpg\",\"datePublished\":\"2021-11-25T10:37:00+00:00\",\"dateModified\":\"2021-11-25T10:45:50+00:00\",\"description\":\"Holger Krenz, Vice President Applications Development Europe, at SiO2 Material Science, is together with his team responsible for the European customer activities to support the commercialization of SiO2\u00b4s product portfolio.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/holger-krenz\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/holger-krenz\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/holger-krenz\/#primaryimage\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Holger-Krenz_BioTech_Pharma_Summit_2021_Profile.jpg\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Holger-Krenz_BioTech_Pharma_Summit_2021_Profile.jpg\",\"width\":900,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/holger-krenz\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pre-filled Syringes &#038; Injectables 2021 Speakers\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Holger Krenz\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"name\":\"BioTech Pharma Summit\",\"description\":\"The Tomorrow&#039;s healthcare congress\",\"publisher\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\",\"name\":\"EPM Group\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"width\":2000,\"height\":2000,\"caption\":\"EPM Group\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/biotechpharmasummit\/\",\"https:\/\/x.com\/biotechsummit\",\"https:\/\/www.instagram.com\/biotechpharmasummit\/\",\"https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Holger Krenz &#8226; BioTech Pharma Summit","description":"Holger Krenz, Vice President Applications Development Europe, at SiO2 Material Science, is together with his team responsible for the European customer activities to support the commercialization of SiO2\u00b4s product portfolio.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/holger-krenz\/","og_locale":"en_US","og_type":"article","og_title":"Holger Krenz &#8226; BioTech Pharma Summit","og_description":"Holger Krenz, Vice President Applications Development Europe, at SiO2 Material Science, is together with his team responsible for the European customer activities to support the commercialization of SiO2\u00b4s product portfolio.","og_url":"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/holger-krenz\/","og_site_name":"BioTech Pharma Summit","article_publisher":"https:\/\/www.facebook.com\/biotechpharmasummit\/","article_modified_time":"2021-11-25T10:45:50+00:00","og_image":[{"width":900,"height":900,"url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Holger-Krenz_BioTech_Pharma_Summit_2021_Profile.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@biotechsummit","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/holger-krenz\/","url":"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/holger-krenz\/","name":"Holger Krenz &#8226; BioTech Pharma Summit","isPartOf":{"@id":"https:\/\/www.biotechpharmasummit.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/holger-krenz\/#primaryimage"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/holger-krenz\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Holger-Krenz_BioTech_Pharma_Summit_2021_Profile.jpg","datePublished":"2021-11-25T10:37:00+00:00","dateModified":"2021-11-25T10:45:50+00:00","description":"Holger Krenz, Vice President Applications Development Europe, at SiO2 Material Science, is together with his team responsible for the European customer activities to support the commercialization of SiO2\u00b4s product portfolio.","breadcrumb":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/holger-krenz\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/holger-krenz\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/holger-krenz\/#primaryimage","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Holger-Krenz_BioTech_Pharma_Summit_2021_Profile.jpg","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Holger-Krenz_BioTech_Pharma_Summit_2021_Profile.jpg","width":900,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/holger-krenz\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biotechpharmasummit.com\/"},{"@type":"ListItem","position":2,"name":"Pre-filled Syringes &#038; Injectables 2021 Speakers","item":"https:\/\/www.biotechpharmasummit.com\/index.php\/pre-filled-syringes-injectables-2021-speakers\/"},{"@type":"ListItem","position":3,"name":"Holger Krenz"}]},{"@type":"WebSite","@id":"https:\/\/www.biotechpharmasummit.com\/#website","url":"https:\/\/www.biotechpharmasummit.com\/","name":"BioTech Pharma Summit","description":"The Tomorrow&#039;s healthcare congress","publisher":{"@id":"https:\/\/www.biotechpharmasummit.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.biotechpharmasummit.com\/#organization","name":"EPM Group","url":"https:\/\/www.biotechpharmasummit.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","width":2000,"height":2000,"caption":"EPM Group"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/biotechpharmasummit\/","https:\/\/x.com\/biotechsummit","https:\/\/www.instagram.com\/biotechpharmasummit\/","https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/37225","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/comments?post=37225"}],"version-history":[{"count":3,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/37225\/revisions"}],"predecessor-version":[{"id":37233,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/37225\/revisions\/37233"}],"up":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/35042"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media\/37226"}],"wp:attachment":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media?parent=37225"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}